Chemical Works of Gedeon Richter Plc (RGEDF)
43.76
+0.45
(+1.04%)
USD |
OTCM |
Aug 25, 16:00
Chemical Works of Gedeon Richter Price to Book Value : 1.835 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 1.835 |
| August 24, 2026 | 1.816 |
| August 21, 2026 | 1.753 |
| August 20, 2026 | 1.753 |
| August 19, 2026 | 1.782 |
| August 18, 2026 | 1.749 |
| August 17, 2026 | 1.762 |
| August 14, 2026 | 1.786 |
| August 13, 2026 | 1.74 |
| August 12, 2026 | 1.764 |
| August 11, 2026 | 1.739 |
| August 10, 2026 | 1.683 |
| August 07, 2026 | 1.667 |
| August 06, 2026 | 1.594 |
| August 05, 2026 | 1.710 |
| August 04, 2026 | 1.608 |
| August 03, 2026 | 1.593 |
| July 31, 2026 | 1.590 |
| July 30, 2026 | 1.587 |
| July 29, 2026 | 1.555 |
| July 28, 2026 | 1.576 |
| July 27, 2026 | 1.553 |
| July 24, 2026 | 1.551 |
| July 23, 2026 | 1.551 |
| July 22, 2026 | 1.531 |
| Date | Value |
|---|---|
| July 21, 2026 | 1.606 |
| July 20, 2026 | 1.606 |
| July 17, 2026 | 1.617 |
| July 16, 2026 | 1.618 |
| July 15, 2026 | 1.592 |
| July 14, 2026 | 1.633 |
| July 13, 2026 | 1.593 |
| July 10, 2026 | 1.643 |
| July 09, 2026 | 1.592 |
| July 08, 2026 | 1.640 |
| July 07, 2026 | 1.640 |
| July 06, 2026 | 1.660 |
| July 02, 2026 | 1.667 |
| July 01, 2026 | 1.662 |
| June 30, 2026 | 1.660 |
| June 29, 2026 | 1.621 |
| June 26, 2026 | 1.660 |
| June 25, 2026 | 1.690 |
| June 24, 2026 | 1.631 |
| June 23, 2026 | 1.581 |
| June 22, 2026 | 1.601 |
| June 18, 2026 | 1.608 |
| June 17, 2026 | 1.650 |
| June 16, 2026 | 1.650 |
| June 15, 2026 | 1.668 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 10.86 |
| ANI Pharmaceuticals, Inc. | 2.873 |
| Corcept Therapeutics, Inc. | 18.74 |
| Veru, Inc. | 1.646 |
| Avadel Pharmaceuticals Plc | -- |
Price to Book Value Related Metrics
| PE Ratio | 12.16 |
| PS Ratio | 2.826 |
| PEG Ratio | 1.121 |
| Price to Free Cash Flow | 9.909 |
| Price | 43.76 |
| Earnings Yield | 8.23% |
| Market Cap | 8.012B |
| PEGY Ratio | 0.7718 |
| Operating PE Ratio | 7.978 |
| Normalized PE Ratio | 12.16 |